4.6 Review

JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications

期刊

出版社

SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10238-023-01047-8

关键词

Hepatocellular carcinoma; Hepcidin; Iron; JAK/STAT; Metabolism

向作者/读者索取更多资源

Iron metabolism plays a crucial role in hepatocellular carcinoma (HCC), and excessive iron accumulation can increase the risk of HCC. Dysregulation of iron metabolism-related proteins and signaling pathways such as the JAK/STAT pathway is observed in HCC. Understanding the crosstalk between iron metabolism and the JAK/STAT pathway is important for preventing or treating iron overload in HCC.
Iron metabolism plays a crucial role in the development and progression of hepatocellular carcinoma (HCC), the most common type of primary liver cancer. Iron is an essential micronutrient that is involved in many physiological processes, including oxygen transport, DNA synthesis, and cellular growth and differentiation. However, excessive iron accumulation in the liver has been linked to oxidative stress, inflammation, and DNA damage, which can increase the risk of HCC. Studies have shown that iron overload is common in patients with HCC and that it is associated with a poor prognosis and reduced survival rates. Various iron metabolism-related proteins and signaling pathways such as the JAK/STAT pathway are dysregulated in HCC. Moreover, reduced hepcidin expression was reported to promote HCC in a JAK/STAT pathway-dependent manner. Therefore, it is important to understand the crosstalk between iron metabolism and the JAK/STAT pathway to prevent or treat iron overload in HCC. Iron chelators can bind to iron and remove it from the body, but its effect on JAK/STAT pathway is unclear. Also, HCC can be targeted by using the JAK/STAT pathway inhibitors, but their effect on hepatic iron metabolism is not known. In this review, for the first time, we focus on the role of the JAK/STAT signaling pathway in regulating cellular iron metabolism and its association with the development of HCC. We also discuss novel pharmacological agents and their therapeutic potential in manipulating iron metabolism and JAK/STAT signaling in HCC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据